Stay updated with breaking news from Immune Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Rating)’s stock price passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $7.36 and traded as high as $8.71. Alpine Immune Sciences shares last traded at $8.57, with a volume of 181,061 shares. Analyst Ratings Changes Several brokerages […]
Alpine Immune Sciences, Inc. , a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases, today reported financial results... | May 11, 2023
Alpine Immune Sciences (NASDAQ:ALPN – Get Rating) will be posting its quarterly earnings results on Wednesday, May 10th. Alpine Immune Sciences (NASDAQ:ALPN – Get Rating) last released its quarterly earnings results on Thursday, March 23rd. The biotechnology company reported ($0.41) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.27) by ($0.14). […]
Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Rating) saw a significant growth in short interest in the month of March. As of March 31st, there was short interest totalling 1,050,000 shares, a growth of 17.6% from the March 15th total of 892,900 shares. Based on an average daily trading volume, of 84,200 shares, the days-to-cover […]
Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Rating)’s share price passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $7.19 and traded as high as $8.10. Alpine Immune Sciences shares last traded at $8.09, with a volume of 62,603 shares traded. Analyst Upgrades and Downgrades […]